Cargando...
Response to imatinib mesylate in childhood chronic myeloid leukemia in chronic phase
INTRODUCTION: Childhood chronic myeloid leukemia (CML) accounts for less than 3% of all childhood leukemias, hence, data on imatinib (IM) in adult CML patients has been largely extrapolated to children. We have analyzed our data to add to the existing literature. AIMS: Primary objective is to assess...
Guardado en:
| Publicado en: | South Asian J Cancer |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4236696/ https://ncbi.nlm.nih.gov/pubmed/25422804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.142961 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|